搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Max Planck Society
17 小时
Adrenomedullin causes diabetes in overweight people
In nine out of ten patients with type 2 diabetes, severe obesity, known as adiposity, leads to diabetes. Type 2 diabetes is ...
3 小时
on MSN
Barclays cuts ConocoPhillips target to $135, keeps Overweight rating
Barclays (LON:BARC) analyst Jeanine Wai adjusted the price target for ConocoPhillips stock (NYSE:COP) to $135 from the ...
2 天
on MSN
New study confirms you can be overweight and healthy if you do this one thing
Want to live longer? A new groundbreaking study reveals what to focus on for a healthy, long life and it is not weight loss.
3 小时
on MSN
Cantor Fitzgerald maintains NBIX overweight with $170 target
Cantor Fitzgerald reaffirmed its Overweight rating on Neurocrine Biosciences stock (NASDAQ:NBIX) with a consistent price target of $170.00. Currently trading at $150.51, the stock has shown strong ...
Ottawa Citizen on MSN
8 天
Almost three-quarters of Canadian troops are overweight or obese: documents
Forty-four percent of personnel in the Canadian Armed Forces are considered overweight while 28 per cent are classified as ...
11 天
LVMH raised to 'overweight' rating by Morgan Stanley analysts
Investment bank Morgan Stanley has raised its rating on French luxury goods giant LVMH to 'overweight' from 'equal weight'.
1 天
Kent Police footage shows commercial vehicles with overweight loads stopped in road safety ...
Kent Police is targeting commercial vehicles with insecure and overweight loads in a two-week road safety campaign. | ITV ...
1 天
AST SpaceMobile initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald initiated coverage of AST SpaceMobile (ASTS) with an Overweight rating and $30 price target The firm says AST’s strategic ...
BioSpace
11 天
Veru’s Drug Spares Lean Mass in Overweight, Obese Adults on Wegovy—Is It Enough?
Patients taking Novo Nordisk’s Wegovy plus Veru’s enobosarm saw 71% lower lean mass loss than those who were taking Wegovy ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈